NCT00344110View on ClinicalTrials.gov

Study Comparing SPP100 (Aliskiren) 150mg to Placebo and to Losartan 50mg in Patients With Mild to Moderate Essential Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

768

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Hypertension
Interventions
DRUG

Aliskiren

Trial Locations (1)

Unknown

Novartis Pharmaceuticals, Japan

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY